Michael Farber
Lawyers
Filters
Arrow Electronics, Inc. $500 Million Notes Offering
Davis Polk advised the joint book-running managers in connection with an offering of $500 million aggregate principal amount of 3.250% senior notes due 2024 issued by Arrow Electronics…
Intercontinental Exchange $1 Billion Notes Offering
Davis Polk advised the joint book-running managers in connection with an SEC-registered debt offering by Intercontinental Exchange, Inc. of $500 million aggregate principal amount of…
Ciena Corporation Exchange Offer
Davis Polk advised the dealer manager on Ciena Corporation’s offer to exchange up to $350 million aggregate principal amount at maturity of outstanding 3.75% convertible senior notes…
Davis Polk Advises Compass Bank on Its $750 Million Senior Notes Offering
Davis Polk advised Compass Bank, a wholly owned subsidiary of BBVA Compass Bancshares, Inc., in connection with the offering of $750 million aggregate principal amount of its 2.875% senior…
Arcor S.A.I.C. $150 Million Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S notes offering by Arcor S.A.I.C. of an aggregate principal amount of an…
Arrow Electronics, Inc. $500 Million Notes Offering
Davis Polk advised the joint book-running managers in connection with an offering of $500 million aggregate principal amount of 3.875% senior notes due 2028 issued by Arrow Electronics, Inc…
Alnylam Pharmaceuticals, Inc. Common Stock Offering
Davis Polk advised the sole book-running manager of a $359.35 million SEC-registered offering of 5,000,000 shares of common stock of Alnylam Pharmaceuticals, Inc. Alnylam’s common stock is…
Kaman $175 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A offering by Kaman Corporation of $175 million aggregate principal amount of its 3.25%…
AMAG Pharmaceuticals, Inc. $300 Million Convertible Senior Notes Offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by AMAG Pharmaceuticals, Inc. of $300 million aggregate principal amount of its 3.25% convertible…
Tellurian Inc. $200 Million SEC-Registered At-The-Market Offering
Davis Polk advised the sole sales agent in connection with an SEC-registered at-the-market offering by Tellurian Inc. of its shares of common stock having an aggregate offering price of up…